Blemish Spot Treatment (Salicylic Acid) 1% recall
FDA recall D-0487-2026 · initiated Apr 1, 2026
Island Kinetics, Inc. d.b.a. CoValence Laboratories recalled Blemish Spot Treatment (Salicylic Acid) 1% in Apr 2026 — an FDA Class II recall (D-0487-2026) because Failed Stability Specifications.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Failed Stability Specifications
Wrong strength, or it did not keep
The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 28,163 bottles
Details
- Product
- Blemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ 85226, UPC 6 10563 13873 9.
- Recalling company
- Island Kinetics, Inc. d.b.a. CoValence Laboratories
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- U.S. Nationwide
- Initiated
- Apr 1, 2026
- FDA report date
- Apr 22, 2026
Frequently asked
- Was Blemish Spot Treatment (Salicylic Acid) 1% recalled?
- Island Kinetics, Inc. d.b.a. CoValence Laboratories recalled Blemish Spot Treatment (Salicylic Acid) 1% in Apr 2026 — an FDA Class II recall (D-0487-2026) because Failed Stability Specifications. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Blemish Spot Treatment (Salicylic Acid) 1% recalled?
- Per the FDA enforcement record, the reason for recall D-0487-2026 was: Failed Stability Specifications
- Is a recalled Blemish Spot Treatment (Salicylic Acid) 1% dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Blemish Spot Treatment (Salicylic Acid) 1% are affected?
- Distributed: U.S. Nationwide. The recall covers these lots — Lot#: 4228D2, 4229D1, Exp.: 07/31/2026 Lot#: 5147D2, Exp.: 04/30/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0487-2026.